Spotlight
Clinical Role
Clinical
Supplement Spotlight
CE
Subscribe
Comparing and Contrasting the Characteristics of the FDA-Approved Pneumococcal Vaccines
The pneumococcal vaccination experts offer a comparative analysis of the five FDA-approved pneumococcal vaccines, focusing on their structural differences and the specific strains each vaccine targets.
EP: 1.Symptomatology and Transmission of Pneumococcal Infection
EP: 2.Manifestation of Pneumococcal Disease in Adults
EP: 3.High-Risk Populations for Severe Pneumococcal Infection
EP: 4.Patient Burden Associated with Pneumococcal Disease
EP: 5.Vaccination Efforts to Mitigate Pneumococcal Outbreaks
Now Viewing
EP: 6.Comparing and Contrasting the Characteristics of the FDA-Approved Pneumococcal Vaccines
EP: 7.Target Patient Populations for Pneumococcal Vaccines
EP: 8.ACIP Recommendations for Pneumococcal Vaccination
EP: 9.Clinical Considerations for Pneumococcal Vaccination Scheduling
EP: 10.Clinical Data Supporting Pneumococcal Vaccination
- Please compare the 5 currently FDA-approved pneumococcal vaccines with regards to vaccine structure and how the strains they target differ.
- How is the structure of covalent different from the structure of conjugate products.
- How is the structure of covalent different from the structure of conjugate products.
Recent Videos
Related Content
